Hopefully: This is one of the ideas behind targeted therapy. One of the first successful approaches has been in chronic myelogenous leukemia where the abnormal protein that causes cell division at an enhanced rate is blocked by a designer molecule. This has resulted in long term remissions and preference for this approach over the prior gold standard of allogeneic bone marrow transplantation.
Answered 3/13/2019
6.2k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
2 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question